# The Effects of Cannabidiol and ∆-9-THC in Humans

> **NCT01180374** · EARLY_PHASE1 · COMPLETED · sponsor: **Yale University** · enrollment: 27 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Cannabidiol
- **DRUG:** Delta-9-THC
- **DRUG:** Placebo
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01180374
- **Lead sponsor:** Yale University
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-02-01
- **Primary completion:** 2014-10-06
- **Final completion:** 2014-10-06
- **Target enrollment:** 27 (ACTUAL)
- **Last updated:** 2022-01-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01180374

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01180374, "The Effects of Cannabidiol and ∆-9-THC in Humans". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01180374. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*